SUMMARY
Paul Schofield, of Cambridge University, discusses the advantages of including histopathological analysis in large-scale mouse mutant phenotyping pipelines. Narrated by Sarah E. Allan. To listen to this podcast, visit http://www.biologists.com/DMM/podcasts/index.html.
This content is only available via PDF.
2012